CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) In Thousands, except Per Share data	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
Net revenues	$ 5	$ 8	$ 19	$ 24
Operating expenses
Cost of revenues		1		1
Research and development, net of settlement of trade debt of $15 for the nine months ended September 30, 2011	56	83	171	213
Selling, general and administrative, (net of settlement of trade debt of $71 for the nine and three months ended September, 30 2010)	460	495	1,294	1,297
Total operating expenses	516	579	1,465	1,511
Operating loss	(511)	(571)	(1,446)	(1,487)
Other income (expense)
Benefit from derivative liability		56	30	238
Interest expense - related party	(45)		(124)
Interest expense	(4)	(23)	(10)	(52)
Total other income (expense)	(49)	33	(104)	186
Net loss	(560)	(538)	(1,550)	(1,301)
Preferred stock dividend	(67)	(67)	(199)	(199)
Net loss applicable to common stockholders	$ (627)	$ (605)	$ (1,749)	$ (1,500)
Basic and diluted net loss per common share	$ (0.01)	$ (0.01)	$ (0.03)	$ (0.03)
Basic and diluted weighted average number of common shares outstanding	59,759,909	46,608,865	55,644,245	47,141,033